Ocular adverse events associated with GLP-1 receptor agonists: a real-world study based on the FAERS database and network pharmacology
Ferrannini, E., Balkau, B., Coppack, S
Desarrollada inicialmente como inyeccin, la formulacin como comprimido se utiliza desde 2019, tras la aprobacin de la FDA
Cardiovascular Research, 90 (3), 529537
For patients experiencing mild to moderate GI symptoms, initial management should focus on non-pharmacological interventions, including smaller and more frequent meals, avoidance of high-fat or spicy foods, cessation of eating upon early satiety, and adequate hydration and fiber intake
Moreover, delayed gastric emptying can interfere with semaglutides absorption, undermining its effectiveness